MétaCan
Menu
Back to cohort
Record W2346341352 · doi:10.1016/j.bbmt.2016.04.013

Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

2016· article· en· W2346341352 on OpenAlexaff
Marcelo C. Pasquini, Jennifer Le‐Rademacher, Xiaochun Zhu, Andrew Artz, John F. DiPersio, Hugo F. Fernández, Shin Mineishi, Masaru Kamishohara, Jayesh Mehta, Yuki Nakamura, Voravit Ratanatharathorn, Ronald Sobecks, Jeanne Burkart, Christopher Bredeson

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2016
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsOttawa Hospital
FundersOffice of Naval ResearchU.S. Public Health ServiceOnyx PharmaceuticalsHealth Resources and Services AdministrationOtsuka PharmaceuticalMiltenyi BiotecIncyteTelomere DiagnosticsSunesisJazz PharmaceuticalsGenentechSeattle GeneticsNational Heart, Lung, and Blood InstituteNovartis Pharmaceuticals CorporationTherakosSigma-Tau PharmaceuticalsMedical College of WisconsinUniversity of MinnesotaMerckSpectrum PharmaceuticalsNational Marrow Donor ProgramSt. Baldrick's FoundationNational Institute of Allergy and Infectious DiseasesRoswell Park Cancer InstituteFred Hutchinson Cancer Research CenterPharmacyclicsHealth ResearchNational Cancer InstituteGilead SciencesLeukemia and Lymphoma SocietyGenzymeAlexion PharmaceuticalsBe The Match FoundationOtsuka America PharmaceuticalAmgenCelgeneHistoGeneticsWellPointSanofi
KeywordsMedicineBusulfanFludarabineCumulative incidenceInternal medicineCyclophosphamideTransplantationHematopoietic stem cell transplantationIncidence (geometry)CohortMyeloidHematopoietic cellOncologyGastroenterologyChemotherapyStem cellHaematopoiesis

Abstract

fetched live from OpenAlex

Busulfan (Bu)-containing regimens are commonly used in myeloablative conditioning regimens before allogeneic hematopoietic cell transplantation (HCT). Yet, there is considerable variability on how Bu is administered related to frequency (4 times a day [Q6] or daily [Q24]) and combinations with other chemotherapeutic agents (cyclophosphamide [Cy] or fludarabine [Flu]). We performed a prospective cohort study of recipients of Bu-based conditioning according to contemporary practices to compare different approaches (BuCy Q6, n = 495; BuFlu Q24, n = 331; BuCy Q24, n = 96; BuFlu Q6, n = 91) in patients with myeloid malignancies between 2009 and 2011. BuFlu Q24 recipients were more likely to be older and tended to have worse performance status and a higher comorbid burden. The cumulative incidences of hepatic veno-occlusive disease (P = .40), idiopathic pneumonia (P = .50), and seizures (P = .50) did not differ across groups. One-year HCT-related mortality ranged from 12% to 16% (P = .80), 3-year relapse incidence ranged from 32% to 36% (P = .80), and 3-year overall survival ranged from 51% to 58% (P = .20) across groups. This study demonstrates that HCT conditioning regimens using i.v. Bu Q6 or Q24 alone or in combination with Cy or Flu have similar outcomes in the myeloablative setting for treatment of myeloid malignancies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.252
Teacher spread0.238 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations26
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicHematopoietic Stem Cell TransplantationFrench-language works237,207